Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial protein synthesis is the essential process by which bacteria create proteins necessary for their survival, growth, and function. It occurs in the cytoplasm using 70S ribosomes (30S and 50S subunits) and involves the translation of mRNA into polypeptide chains. This process is a major target for antibiotics due to key differences between bacterial and eukaryotic ribosomes, allowing for selective inhibition of bacterial growth. The steps include initiation (assembly of ribosomal subunits and initiator tRNA), elongation (sequential addition of amino acids based on mRNA codons), termination (release of the polypeptide chain), and ribosome recycling. A unique feature is the use of N-formylmethionine (fMet) as the initiator tRNA. Antibiotics targeting this pathway include aminoglycosides, tetracyclines, macrolides, chloramphenicol, and linezolid.
Inhibition of bacterial ribosome function, leading to disruption of protein synthesis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Protein Synthesis.